✦ LIBER ✦

214 Deregulated expression of BARD1 in human tumors; a novel diagnostic and prognostic marker

✍ Scribed by I. Irminger-Finger; J. Wu; A. Vlastos; M. Pelte; A. Bianco; G. Laurent

Book ID: 118621397
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 137 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80222-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

l-DOPA Decarboxylase (DDC) Expression St

l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer

✍ Patsis, Christos (author);Glyka, Vasiliki (author);Yiotakis, Ioannis (author);Fr 📂 Article 📅 2012 🏛 Neoplasia Press Inc 🌐 English ⚖ 479 KB

l-DOPA Decarboxylase (DDC) Expression St

l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer

✍ Patsis, Christos (author);Glyka, Vasiliki (author);Yiotakis, Ioannis (author);Fr 📂 Article 📅 2012 🏛 Neoplasia Press Inc 🌐 English ⚖ 479 KB

Expression of survivin mRNA in gallbladd

Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?

✍ Nigam, Jaya; Chandra, Abhijit; Kazmi, Hasan Raza; Parmar, Devendra; Singh, Deven 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 292 KB

267 High ZNF217 Expression Level is a No

267 High ZNF217 Expression Level is a Novel Prognostic Marker in Breast Cancer and Deregulated ZNF217 Expression is Associated With Aggressive Phenotype

✍ J. Vendrell; A. Thollet; N.T. Nguyen; I. Bieche; E. Grisard; P. Roux; L. Corbo; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Expression of the Ca2+-selective cation

Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression

✍ Fixemer, Thomas; Wissenbach, Ulrich; Flockerzi, Veit; Bonkhoff, Helmut 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

Assessment of procalcitonin as a diagnos

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

✍ Antonio Jimeno; Adelaida García-Velasco; Olga del Val; Enrique González-Billalab 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## BACKGROUND Cancer patients with fever and neutropenia currently are assessed on clinical grounds only. The current study prospectively evaluated the efficacy of baseline procalcitonin (PCT) in the detection of bacteremia and in the prediction of outcome in patients with solid tumors